HAEM5:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes: Difference between revisions
| [pending revision] | [pending revision] |
| Line 41: | Line 41: | ||
|- | |- | ||
|WHO Desirable Criteria (Genetics)* | |WHO Desirable Criteria (Genetics)* | ||
|Cytogenetic translocation suggesting a potential involvement of a tyrosine kinase gene, with selection of a FISH break-apart probe or another molecular assay for confirmation. | |Cytogenetic translocation suggesting a potential involvement of a tyrosine kinase gene, with selection of a FISH break-apart probe or another molecular assay for confirmation. | ||
|- | |- | ||
|Other Classification | |Other Classification | ||
| Line 52: | Line 52: | ||
|+ | |+ | ||
|Acceptable | |Acceptable | ||
| | |Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes, Other and unspecified myeloproliferative neoplasms. | ||
|- | |- | ||
|Not Recommended | |Not Recommended | ||
| | |Myeloid/lymphoid neoplasms with tyrosine kinase fusion genes (NOS). | ||
|} | |} | ||